Results 171 to 180 of about 189,515 (386)
A CASE OF CHRONIC ECZEMA FOLLOWED BY FATAL GANGRENE [PDF]
G. H. Lancashire
openalex +1 more source
ABSTRACT Background Pyoderma gangrenosum (PG) is a challenging inflammatory skin disorder. While corticosteroids offer a rapid response, their long‐term risks necessitate alternative treatments. Objective To compare the long‐term effectiveness of biologic therapies versus systemic corticosteroids in PG management. Methods A retrospective analysis of 15
R. Cascio Ingurgio+8 more
wiley +1 more source
This study evaluated 28‐week safety and effectiveness of tralokinumab treatment in patients with atopic dermatitis. All primary outcomes significantly improved during 28 weeks of tralokinumab treatment and the probability of achieving EASI ≤ 7 and NRS‐pruritis ≤ 4 was 75.8% (56.9–88.2) and 51.4% (28.0–74.2), respectively.
Coco Dekkers+16 more
wiley +1 more source
Atopic Eczema is a non-contagious skin disease. This study was undertaken to determine the role of home environment allergens in aggravation of atopic eczema by using EASI (Eczema Area And Severity Index) and POEM (Patient Oriented Eczema Measure ...
Bisma Laeeque+3 more
doaj
Eczema in early childhood increases the risk of allergic multimorbidity
Background Eczema in early childhood is associated with the development of subsequent allergic diseases, including food allergy (FA), asthma and hay fever.
L. A. Miltner+3 more
doaj +1 more source
Whole exome sequencing detects novel variants in Saudi children diagnosed with eczema
Background: Eczema is also known as atopic dermatitis is well-known for the skin disease globally. In Saudi Arabia, exome sequencing studies have not been documented.
Neda M. Bogari+21 more
doaj